Dr. Daniel Labow is the founder and leader of one of the country’s most popular hyperthermic intraperitoneal chemoperfusion (HIPEC) programs at Mount Sinai Health System in New York. HIPEC, also called heated chemotherapy, treats individuals with peritoneal mesothelioma and other abdominal cancers. Like other top mesothelioma doctors, Dr. Labow regularly uses HIPEC to help improve the life expectancy of his patients.
Speak with our patient care advocates to get paired with the best doctors
Available for ChatDaniel Labow is one the world’s leading experts in heated chemotherapy treatment for peritoneal mesothelioma.
He is known for prioritizing the needs of his patients. Dr. Labow uses minimally invasive treatments wherever possible in order to maximize patients’ comfort and accelerate their recovery.
Dr. Labow has been employed at Mount Sinai Health System since 2004. As founder and director of its HIPEC program, Dr. Labow has performed hundreds of life-saving chemotherapy procedures.
HIPEC is a procedure that combines cytoreductive surgery with heated chemotherapy to remove mesothelioma tumors from the abdominal lining.
After a tumor has been removed, the organs and tissues potentially affected by cancer cells are bathed in a warmed chemotherapy solution. Infected areas of the body are directly targeted by the medical solution, which is then absorbed by the body.
Dr. Labow has dedicated his career to improving his patients’ health and quality of life.
Some of his biggest career accomplishments include:
Download our Free Questions to Ask Your Doctor Checklist before meeting with Dr. Labow or any mesothelioma specialist to ensure you get the answers you need.
Dr. Daniel Labow earned a bachelor’s degree in biology from the University of Pennsylvania. He then attended medical school at Brown University before completing his general surgery residency at the University of Chicago.
Dr. Labow also completed a second residency at New York-Presbyterian Weill Cornell Medical Center and a fellowship in surgical oncology at the Memorial Sloan-Kettering Cancer Center.
Now at Mount Sinai Health in New York City, he is particularly dedicated to improving its educational program and is actively developing new processes to improve the patient experience.
Dr. Labow focuses on a wide range of specialties in addition to mesothelioma and HIPEC.
Some of his other medical specializations include:
Dr. Labow has dedicated much of his professional career to his work at Mount Sinai Hospital’s cancer center. He has run several clinical trials in an effort to further cancer research and find the best treatments available.
He has published dozens of medical articles and mentored upcoming surgical oncologists at the Icahn School of Medicine at Mount Sinai. Dr. Labow personally championed the hospital’s HIPEC program in the early 2000s, when heated chemotherapy was still a relatively new treatment with many skeptics.
“[HIPEC is] quite unique in combating cancer and getting improved outcomes for patients who often only had months to live. We are getting patients that usually survive only months and are now living multiple years.”
– Dr. Daniel Labow
To date, Dr. Labow has performed more than 600 heated chemotherapy procedures and helped prove HIPEC’s viability as a cancer treatment. He is now one of the most experienced surgeons in the world when it comes to treating peritoneal mesothelioma and other abdominal cancers.
Use our Free Doctor Match to find top specialists near you who can treat your peritoneal mesothelioma.
Dr. Labow is extremely knowledgeable about numerous forms of cancers and has applied his extensive research to a wide range of medical challenges. Much of his experience is with abdominal cancers like pleural mesothelioma, but he also works with appendiceal, gastric, ovarian, and colon cancer patients.
““As we learn more and more about these diseases — how they start, identifying them on a genetic level, and really profiling patients and categorizing and personalizing their care — we can really impact patients more directly.”
– Dr. Daniel Labow
In a review of peritoneal mesothelioma cases, Dr. Labow looked at the existing research in hopes of helping the medical community better understand, diagnose, and treat this form of cancer in the future.
Because it is rarer than pleural mesothelioma, peritoneal mesothelioma is not as extensively researched and understood.
Dr. Labow’s review highlighted some of the challenges associated with the disease, including diagnostic difficulties, inaccurate staging, and the need for improved therapies.
The study recognized that cytoreductive surgery with HIPEC is the most common first line of defense, but that chemotherapy may be a more suitable treatment for some patients.
Dr. Labow ultimately concluded that while existing treatments have improved, these advancements aren’t enough to drastically improve survival rates.
He also found that research into signaling pathways — which are networks of multiple proteins that transmit signals and initiate cellular response — is promising and should continue to be pursued. Data shows that drugs developed to target specific molecules involved in these pathways may help keep cancer cells from growing.
Dr. Labow believes strongly in both treatment and preventative care.
He has played an integral role in shaping Mount Sinai’s educational programs and philosophy toward health care, which is “to provide compassionate patient care with seamless coordination and to advance medicine through unrivaled education, research, and outreach in the many diverse communities we serve.”
Dr. Labow uses his leadership, outreach, education, clinical experience, and research to help achieve the hospital’s vision, working to deliver the best possible results for every patient.
Get your copy of our Free Mesothelioma Guide to learn about top doctors, treatments, and clinical trials — shipped overnight to your door.
If you’ve been diagnosed with peritoneal mesothelioma, you may be eligible for cytoreductive surgery with HIPEC. This procedure has helped several peritoneal mesothelioma patients live longer with fewer symptoms.
We can help you connect with Dr. Labow and other top mesothelioma doctors who provide this gold-standard treatment.
Call us at (866) 608-8933 today — our Patient Advocates can get you in touch with Dr. Labow’s team so you can start your treatment journey.
Mesothelioma Hope has no affiliation with and is not endorsed or sponsored by Dr. Daniel Labow. Any contact information listed is for informational purposes only. You have the right to contact Dr. Daniel Labow directly.
Written by:Laura WrightLaura Wright is a journalist and content strategist with more than 14 years of professional experience. She attended college at the University of Florida, graduating magna cum laude with a bachelor’s degree in journalism in 2008. Her writing has been featured in The Gainesville Sun and other regional publications throughout Florida.
Connect with top mesothelioma specialists near you.
Explore 90+ pages on life-extending treatments, veterans support, financial aid & more.
If you or someone you love has been diagnosed with mesothelioma, there is hope. Contact us to learn more about mesothelioma and your treatment options.
Submit your information and a Patient Advocate will call you right back!
Hello, we’re sorry to barge in, but we are available to answer your questions.
Would you like to speak to a live person?
